ARTL

Artelo Biosciences Inc Cross-source read$5.43 3.55%
Health CareCUSIP 04301G706· EOD Sep 11, 2026

Among active 13F managers last quarter, 1 opened and 1 added, while none reduced or exited; the largest holder to move was Tower Research Capital LLC (TRC) (+49%). No open-market insider trades in the last 180 days.

Tracked 13F holders
12
13F value (tracked)
$189K
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
2 adding · 0 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$5.43 3.55%5Y -99.7%
$5.00$679.42$1,354$2,028$2,70320212022202320242025202623
Hover for who · click for detailEnd-of-day closing prices52w $5.43 – $159.03

Who owns ARTL?

12 tracked 13F filers · ranked by shares held

12 tracked 13F filers disclose a position in ARTL as of the latest SEC 13F filings, a combined $189K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Geode Capital Management, LLC14K
$16K
New
+14K sh
Q2 2026
2Jane Street Group, LLC13K
$99K
New
+13K sh
Q1 2026
3StoneX Group Inc.12K
$15K
New
+12K sh
Q2 2026
4Vanguard Capital Management LLC10K
$11K
Held
Q2 2026
5Vanguard Fiduciary Trust Co3K
$4K
Held
Q2 2026
6Citigroup Inc3K
$23K
New
+3K sh
Q1 2026
7Tower Research Capital LLC (TRC)3K
$21K
+49%
Added · +923 sh
Q1 2026
8TD Waterhouse Canada Inc.2
$2
New
+2 sh
Q2 2026
9Rothschild Investment LLC2
$2
Held
Q2 2026
10CWM, LLC1
$8
Held
Q1 2026
11Osaic Holdings, Inc.1
$7
Held
Q1 2026
12Danske Bank A/s1
$1
New
+1 sh
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is ARTL being bought or sold by institutions?

Last quarter, 1 fund opened a new position in ARTL and 1 added to an existing one, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
1
fund took a first position
Added
1
added to an existing position
Biggest moves · ranked by size of the change, positions above a floor

Funds that own ARTL also own

CompanyCo-held byTheir position there
Apple IncAAPL3 funds$251.1M
Nvidia CorpNVDA3 funds$206.4M
Invesco QQQ Trust Series 1QQQ3 funds$195.3M
Vanguard S&P 500 ETFVOO3 funds$152.2M
Microsoft CorpMSFT3 funds$151.2M
Alphabet Inc-CL AGOOGL3 funds$134.3M
Micron Technology IncMU3 funds$106.6M
SS SPDR S&P 500 ETF Trust-USSPY3 funds$95.0M
JPMorgan Chase & CoJPM3 funds$94.2M
Amazon.com IncAMZN3 funds$93.7M
Broadcom IncAVGO3 funds$88.1M
Tesla IncTSLA3 funds$85.9M

Ranked by how many of ARTL's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in ARTL.

Insider activity (Form 4)

Full insider page →
Net · 180d
$0
0 open-market transactions
DateInsiderRoleActionSharesValue
Aug 12, 2022Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr, DirectorBuy (P)1K$5K
Aug 11, 2022Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr, DirectorBuy (P)1K$5K
Apr 16, 2021Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr, DirectorBuy (P)9K$10K
May 15, 2020Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr, DirectorBuy (P)4K$5K
May 4, 2020Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr, DirectorBuy (P)4K$5K
May 4, 2020Matsui ConnieDirectorBuy (P)42K$50K
Nov 4, 2019Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr, DirectorBuy (P)2K$5K
Nov 1, 2019Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr, DirectorBuy (P)3K$6K
Oct 31, 2019Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr, DirectorBuy (P)3K$5K
Oct 30, 2019Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr, DirectorBuy (P)3K$5K
Oct 15, 2019Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr, DirectorBuy (P)3K$5K
Oct 11, 2019Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr, DirectorBuy (P)3K$5K

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
10
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
ARTL is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Recent filings

15 most recent

Keep exploring

Connected entities for ARTL

Browse more

Build

Ask your agent what changed in ARTL

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/ARTL/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for ARTL.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ARTL. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.